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INTRODUCTION
It has recently been recognized that subtle rearrangements
at the subtelomeric regions of chromosomes may account
for a significant proportion of cases with unexplained men-
tal retardation (MR) (1). The subtelomeric regions are gene-
rich and are often involved in chromosomal rearrangements
(2). Such rearrangements are typically too small to be detect-
ed by conventional cytogenetic analysis, a technique that
allows detection of rearrangements with a minimum size of
3-5 Mb, if experimental circumstances are optimal and the
banding patterns of the rearranged chromosomal material is
distinctive. In practice, however, the resolution of conven-
tional cytogenetic analysis may be suboptimal. 
There are several laboratory techniques for the screening of
subtelomeric rearrangement, e.g., fluorescent in situ hybridiza-
tion (FISH) analysis using subtelomeric probes, microsatel-
lite marker analyses (3, 4), and high-resolution comparative
genome hybridization (HR-CGH) (5). Recently, the use of
multiplex ligation-dependent probe amplification (MLPA)
(6), multiplex amplifiable probe hybridization (MAPH) (7-
9), real-time quantitative PCR (10), and microarrays (11)
have also been described. A recent review showed that the
frequency of subtelomeric rearrangements in subjects with
MR ranged between 0.5% and 16.3%, according to the defi-
nition of study subjects (Table 1) (12). The wide range of
the frequency might be attributed to one or more of the fol-
lowings; the quality of chromosome preparation and band-
ing, different study techniques used (FISH vs. microsatellite
analysis vs. CGH), methods to confirm the positive findings
from screening (if any), inclusion criteria, patient recruitment
strategies, and the initial clinical evaluation of study sub-
jects (13). 
Here we report our experience of screening of subtelomer-
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Screening of Subtelomeric Rearrangements in 100 Korean Pediatric
Patients with Unexplained Mental Retardation and Anomalies Using
Subtelomeric FISH (Fluorescence In Situ Hybridization)
Rearrangements of the subtelomeric regions of chromosomes account for a signif-
icant proportion of the underlying genetic defects in both idiopathic mental retarda-
tion (MR) and multiple congenital anomalies. To detect the rearrangements, a set
of subtelomeric fluorescence in situ hybridization (FISH) probes has been developed.
The aim of this study was to reveal the frequency of subtelomeric rearrangements
in Korean patients with MR or multiple anomalies. We performed a FISH study using
a commercially available subtelomeric FISH probes on a series of unrelated Korean
pediatric patients with MR or multiple anomalies without identifiable causes. We
used a checklist to evaluate the developmental delay and/or MR. Patients who were
shown to have chromosome abnormalities, metabolic disorders, or recognizable
dysmorphic syndromes by clinical and laboratory findings were excluded. As a result,
100 patients were eligible for the Subtelomeric FISH study, and a total of 29 patients
(29%) were suspected to have subtelomeric rearrangements on initial screening
by the multiprobe FISH kit. Among theses, confirmatory FISH studies by using sin-
gle locus-specific FISH probes were performed in 24 patients. One patient (a 10-
yr-old girl) was confirmed to have rearrangement, deletion of the telomeric portion
of the short arm of chromosome 4 (4p). Her clinical manifestation was compatible
with Wolf-Hirschhorn syndrome, which is known to be caused by 4p deletion. The
frequency of subtelomeric rearrangements in this study was 1.1% (1/95), lower
than those previously reported (0.5-16.3%). We suggest that subtelomeric FISH
test is a useful screening tool for patients with idiopathic MR and/or dysmorphism
regardless of its false positive value. 
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delay and dysmorphic features by using subtelomeric FISH
to assess the usefulness of the technique in identifying the
underlying genetic defects in Korean patients. 
MATERIALS AND METHODS
Patient selection
The study subjects were recruited from three institutions,
Samsung Medical Center, Seoul Metropolitan Children’s
Hospital, and Seoul Clinical Laboratories between January
1996 and December 2003. Basically the patients were referr-
ed to the clinical laboratories for karyotyping by convention-
al cytogenetics. The inclusion criteria were 1) the clinical
indications of MR or developmental delay for cytogenetic
analyses on the test request form, together with dysmorphic
features and/or malformations, or two or more malforma-
tions in case of neonates, since the mental or physical devel-
opmental potential could not be determined at that age and
2) a normal karyotypes on the GTG-banded cytogenetics at
the 400- to 550-band resolution. The degree of MR (mild,
IQ 50 to 70; moderate, IQ 30 to 50; severe, IQ<30) and
scores from the checklist for submicroscopic subtelomeric
rearrangements developed by de Vries et al. (Table 2) (14-
16) were obtained from medical records. 
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Reference Method of analysis Number of study patients Detection rate (%)
Flint et al. [1995] VNTR marker analysis 99 3
Knight et al. [1999] Multiprobe FISH 284 moderate to severe  7.4
182 mild 0.5
Slavotinek et al. [1999] Microsatellite marker analysis 27 7.5
Bonifacio et al. [2001] PRINS 65 3.1
Borgione et al. [2001] Microsatellite marker analysis 60 6.6
Colleaux et al. [2001] Microsatellite marker analysis 29 6.9
Fan et al. [2001] Multiprobe FISH 150 4
Riegel et al. [2001] Multiprobe FISH 254 5
Rosenberg et al. [2001] Microsatellite marker analysis 120 4.1
Rossi et al. [2001] Multiprobe FISH 200 6
Sismani et al. [2001] Multiprobe FISH 70 1.4
Anderlid et al. [2002] MAPH 111 9
Baker et al. [2002] Multiprobe FISH 53 isolated MR 1.9
197 MR and dysmorphic  4.1
features/malformations
Clarkson et al. [2002] Multiprobe FISH, SKY 50 6
Dawson et al. [2002] Multiprobe FISH 40 10
Hellias-Rodzewicz et al. [2002] Multiprobe FISH 33 9
Hollox et al. [2002] MAPH 37 13.5
Popp et al. [2002] M-TEL 30 13.3
Rio et al. [2002] Microsatellite marker analysis 150 10
van Karnebeek et al. [2002] Multiprobe FISH 184 0.5
Hulley et al. [2003] Multiprobe FISH 13 7.7
Jalal et al. [2003] Multiprobe FISH 372 6.8
Bocian et al. [2004] Multiprobe FISH 59 moderate to severe 10
24 mild 12.5
Harada et al. [2004] Array CGH 69 5.8
Koolen et al. [2004] MLPA 210 6.7
Kriek et al. [2004] MAPH 184 4.3
Pickard et al. [2004] MAPH FISH 69 mild 1.5
Rodriguez-Revenga et al. [2004] Multiprobe FISH 8 moderate to severe 12.5
22 mild 4.5
Rooms et al. [2004b] Microsatellite marker analysis 70 -
Rooms et al. [2004a] MLPA 75 5.2
Walter et al. [2004] Multiprobe FISH 50 10
Novelli et al. [2004] Multiprobe FISH 92 16.3
Li and Zhao [2004] Multiprobe FISH 46 4.4
Table 1. A review of the previous studies on subtelomeric screening in a chronological order 
VNTR, variable number tandem repeat; FISH, fluorescence in situ hybridization; PRINS, primed in situ labeling; MAPH, multiplex amplifiable probe
hybridization; MR, mental retardation; CGH, comparative genomic hybridization; MLPA, multiplex ligation-dependent probe amplification.Conventional cytogenetic study and Subtelomeric FISH
analyses
Metaphase chromosome spreads were obtained from blood
lymphocyte cultures using the standard methods. The chro-
mosomes were GTG-banded at 400-band resolution or high-
er and karyotyped. The subtelomeric FISH was performed
by using a commercially available set of probes (Chromo-
probe Multiprobe, Cytocell, Banbury, U.K.), according to
the manufacturer’s instructions. The probes are targeted to
the subtelomeric regions mostly at a 100-300 kb distance
from the end of each of chromosome arms, excluding the
short arms of acrocentric chromosomes.
Two experienced technicians each scored a minimum of
five metaphases per probe in a blind manner, focusing on dele-
tions, duplications, and balanced translocations involving
the subtelomeric regions of every chromosomes. Metaphases
were accepted for analysis if both the p-arm and the q-arm
of two chromosome homologues could be scored. The results
were considered conclusive if the first five metaphases gave
100% concordant results. If any abnormalities were suspect-
ed on screening, the results were confirmed using the single
subtelomeric locus-specific probes targeted to the region of
interest (Aquarius Subtelomere Specific Probe, Cytocell). 
RESULTS
A total of 100 patients were screened for subtelomeric rear-
rangements (42 from Samsung Medical Center, 23 from the
Seoul Metropolitan Children’s Hospital, and 35 from the
Seoul Clinical Laboratories). The patients’ age ranged from
5 months to 27 yr, and the male-to-female ratio was 1.6:1
(62:38). Among them, 16 patients had MR/developmental
delay associated with dysmorphic features; 35 patients had
isolated MR; and 49 patients had isolated dysmorphic fea-
tures and/or malformations. 
MR could be assessed only in patients who were older than
three years (n=53). Among them, 32 patients (32/53; 60%)
were recorded as having MR, and the severity of MR ranged
from mild (IQ<69) to severe (IQ<20). Family history of
MR was documented in five patients. Developmental delay
was noted in 43 patients. Dysmorphic features were observed
in 62 patients with diverse manifestations with facial dys-
morphism being the most frequent. Cleft palate and high-
arched palate were observed in 10 and 7 patients, respective-
ly. Seizure and epilepsy were recorded in 19 patients. Micro-
cephaly, short stature, congenital heart defect, and seizure
frequently accompanied MR (Table 3). 
From the initial screening of 100 patients, subtelomeric
rearrangements were suspected in 29 patients. To confirm
the rearrangement, we performed single-probe FISH analy-
sis in 24 patients; the confirmation step could not be per-
formed in 5 patients; additional samples were not available
in two patients and single FISH probes were not available
in three patients.
As a result, cryptic subtelomeric anomalies were found in
1 child out of 95 patients. The submicroscopic deletion of
4pter was detected on the multiprobe FISH and subsequently
confirmed by single locus-specific FISH analysis (Fig. 1). The
patient was a 3-yr-old girl with mild, non-familial MR. She
was born at 37 weeks, weighing 1,700 g, and had a ventric-
ular septal defect, cleft palate, brachycephaly, malocclusion,
midfacial hypoplasia, frontal bossing, epilepsy, MR, and devel-
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PDA, patent ductus arteriosus; ASD, atrial septal defect; VSD, ventricu-
lar septal defect.
Categories and items Score
Family history of mental retardataion
Compatible with Mendelian inheritance                   1
Incompatible with Mendelian inheritance                  2
Prenatal onset growth retardation (low birth weight)            2
Postnatal growth abnormalities                               2  
For each of the following, 1 point (maximum 2 points)
Microcephaly (1), short stature (1)  
Macrocephaly (1), tall stature (1)
>/= 2 facial dysmorphic features                                2
Non-facial dysmorphism and congenital abnormalities            2
For each anomaly 1 point (maximum 2 points)
Hand anomaly (1), heart anomaly, esp. PDA, ASD, VSD (1)
Hypospadias +/- undescended testis (1)
Table 2. Checklist for patients with submicroscopic subtelom-
eric rearrangements
*, Mental retardation could be determined only in children older than
three years of age (n=53). 
Clinical manifestation Absent Present
Mental retardation*  60% (32/53) 40% (21/53)
Developmental delay 43% (43/100) 57% (57%/100)
Dysmorphic feature 62% (62/100) 38% (38/100)
Congenital heart defect 13% (13/100) 87% (87/100)
Cleft palate 10% (10/100) 90% (90/100)
Seizure 19% (19/100) 81% (81/100)
Microcephaly 12% (12/100) 88% (88/100)
Table 3. The frequencies of clinical features in the study patients
(n=100) 
*, One of the patients with 3 points had a subtelomeric rearrangement. 
Score No. of patients
1 point 28
2 points 22
3 points*  15
4 points 5
≥5 points  2
Total 72
Table 4. Distribution of scores from the checklist in the study
patientsopmental delay. Collectively, her clinical manifestation indi-
cated Wolf-Hirschhorn syndrome, compatible with deletion
4pter. A review of the high-resolution karyotypes showed
that the deletion was not discernible and thus submicroscopic.
The clinical manifestations based on the checklist indicated
a median score of 2 points (range, 1-8) in the patients with-
out subtelomeric rearrangement (n=71), and 3 points in the
subject with subtelomeric rearrangement (n=1) (Table 4).
DISCUSSION
Recently, a five-item clinical checklist was suggested by
de Vries et al. (15) to improve the rate of detection of sub-
telomeric defects among mentally retarded individuals (Table
2). In the present study, this checklist was used and clinical
information was gathered from the test request form for cyto-
genetic analyses. In this case, however, the utility of the check-
list is highly dependent upon the accuracy of the clinical
information given on the request form for cytogenetic anal-
yses. Moreover, the assessment of facial morphology is rather
subjective and should take into account the parental pheno-
types. We also noted two of the criteria on the checklist relat-
ed to the family history of MR. In five patients with a fami-
ly history compatible with Mendelian inheritance, MR in at
least one relative was not associated with subtelomeric rear-
rangement. This does not negate the value of the criterion
but rather highlights its limitation when using it to select
patients for testing. The checklist was developed to help select
cases for subtelomeric testing and consists of five items; the
presence of a family history of MR, prenatal onset of growth
retardation, postnatal growth abnormalities, two or more
facial dysmorphic features, and one or more non-facial dys-
morphic features or congenital abnormalities. Testing of
patients with a clinical score ≥3 increased the diagnostic
yield by fourfold to 4.5% (1/22).
Since subtelomeric deletion was detected only in one patient
out of 100 study patients (1%) screened for the cause of MR,
we concluded that subtelomeric rearrangements might not
be a common cause of MR in Korean pediatric patients. A
recent study (17) suggested that the yield of subtelomeric
screening in patients with unexplained MR depends fore-
most on the quality and resolution of the chromosome stud-
ies and on the nature and severity of the clinical phenotype.
In the present study, the karyotyping analyses were done on
high-resolution metaphases in all study subjects. Our find-
ings are in line with those of some studies (5, 18) that showed
high-resolution banding can detect most ‘‘cryptic’’ subtelom-
eric anomalies. This may explain in part the low rate of sub-
telomeric rearrangements observed in this study. The low
frequency of subtelomeric rearrangements in the present study
may also be explained by the fact that not all studies exclud-
ed the possibility of polymorphisms (19-21). We did not
search for subtelomeric microdeletions in patients with a
cytogenetic anomaly discernible under light microscopy, and
thus possibly missed concurrent microdeletions. However,
the chance of the concurrence is very low. Other explanations
would include: the retrospective nature and the consecutive
enrollment of patients in this study, which might have dimin-
ished biases possibly present in earlier studies. Investigations
of cases with clinically recognizable microdeletion syndromes
(such as 4p-) by separate FISH would have focused on sus-
pected anomalies, and if such anomalies were found, these
cases were excluded from the subtelomeric screening. Final-
ly, differences between the present study cohort and those of
other telomeric studies in terms of the proportions of cases
of familial MR and in the numbers of those with dysmor-
phic features might have contributed. A positive family his-
tory for MR, especially when there are two or more affected
members, has been suggested to indicate the presence of a
subtelomeric defect (15). However, as only one patient was
found to have subtelomeric defect (in a family with a nega-
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Fig. 1. (A) Metaphases fluorescence in situ hybridization (FISH) using subtelomeric multiprobes showed one normal chromosome 4 with
red signals from the subtelomeric region of the long arm and green signals from the subtelomeric region of the short arm (arrow) and the
other copy of chromosome 4 lacking the green signals (headarrow), indicating the deletion of the subtelomeric region of the short arm of
chromosome 4. (B) We confirmed the finding from the multiprobes using a single probe for 4p. Only one chromosome 4 revealed signals
from 4p (arrow), indicating deletion of 4p telomere in the other copy of chromosome 4 (headarrow). (C) Partial G-banded karyotype of
chromosome 4 of this patient. Chromosomal abnormality was not detected via conventional cytogenetic analysis.
A B C
TEL 4p (G)/4q (R) probe
Telomere 4p probe
del (4ptel) 44 4tive history for MR), no correlation studies were possible. 
In the previous subtelomeric screening studies, the pres-
ence of dysmorphic features has been used as an important
selection criterion (18, 20-22). However, the term ‘‘dysmor-
phic features’’ was not further defined in most cases, and the
dysmorphic findings were not subcategorized, which are
mandatory when analyzing the phenotypes. The determina-
tion of dysmorphism is subjective, and the traits are hard to
be quantified. The lack of clear definitions for some of the
symptoms, the absence of reference standards for normality,
and the absence of reliable incidence figures that take into
account the age and ethnic origin of patients, all contribute
to make the definition of dysmorphism unclear. Therefore,
the phenotypic anomalies observed in the present study were
not less frequent than those in other screened groups, and
cannot explain the lower rate of subtelomeric deletions. Final-
ly, another possibility would be that the low rate of positive
cases has occurred by chance. 
Another point to note is that the false positive rate of the
screening using multiprobe FISH was considerably high
(only one out of 24 patients was confirmed to have subtelom-
eric deletion) according to our experience. The main reason
for this finding might be the different reactivities of 24 square
areas, which carry subtelomeric probes for one of the 23 chro-
mosomes, resulting in the different hybridization rate of
subtelomere probe. Thus, we suggest that one should not
make a conclusion on the presence of rearrangement based
solely on the multiprobe FISH but should confirm the rear-
rangement using a single probe FISH specifically targeted
to the subtelomeric region of interest as indicated by multi-
probe FISH.
In many patients referred for subtelomeric screening even
after a long period of laboratory investigations and follow-up,
the identification of subtelomeric rearrangements can be very
helpful, especially in parents at childbearing age because pre-
natal testing and more accurate counseling regarding recur-
rence risks can be offered. Recently, a new methodology called
MLPA has been developed. This method has proven to be
accurate and reliable for identifying deletions, duplications,
and amplifications in several diseases (23-26) as well as for
the screening of subtelomeric rearrangements (6, 12).
We have shown that subtelomeric FISH is helpful in pati-
ents with dysmorphic features and MR of unknown etiolo-
gy with a normal karyotype as a second-line modality in the
laboratory investigation. However, subtelomeric FISH has
also disadvantages in that it is expensiveness and time-con-
suming. The pathogenic role of subtelomeric rearrangements
is not certain, so prospective studies by other, more efficient
techniques, such as MLPA, are needed.
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